A component supplier to the medical device industry, headquartered in San Clemente, California announced today that it is establishing a new medical tubing manufacturing operation in Tullamore, Co. Offaly, with the support of IDA Ireland. Kelcourt Ireland Pte Limited will create 55 new jobs over five years and is making a significant capital investment in its building at the IDA Business and Technology Park in Tullamore.
Kelcourt Plastics, Inc is a division of PPC Industries Inc of Pleasant Prairie, Wisconsin. In late 2010, Kelcourt was acquired by PPC Industries, Inc, a flexible packaging company which focuses on value added packaging for medical, food and industrial markets. PPC also has a growing presence in Europe and is considering options for flexible film conversion in the Kelcourt Irish facility. Kelcourt’s medical tubing capabilities and PPC’s medical packaging portfolio create perfect synergy into a broad range of key medical device applications that will be locally sourced in Ireland. The company also plans to target the European market with its range of medical tubing and packaging solutions.
The Irish operation will also establish a product development function to work closely with client R&D teams on new product concepts. The specialized tubing that will be manufactured at the plant will be used in hundreds of diverse medical products including anesthesia, urology, cardiology, surgery, IV systems and emergency medicine.
Making the announcement today Patrick Mickle, President, Kelcourt said, “We searched for the right location to establish an operation to meet the demand for our medical and speciality tubing capability as well as our packaging capabilities in Ireland. We are very excited to establish a manufacturing facility in Tullamore and we look forward to finding the right calibre of staff to ensure our success here. This also creates the perfect gateway into the growing European market.”
Commenting on the announcement IDA Ireland, CEO Barry O’Leary said, “Kelcourt’s decision to locate this operation in Ireland enhances the medical device supplier base here. Ireland’s reputation as a hub for Life Sciences continues to grow with 8 of the top 10 pharmaceutical and 15 of the top 20 medical devices companies worldwide with operations here.”
“IDA’s strategy, Horizon 2020, sets out to achieve balanced regional development in Gateway locations, and today’s announcement for Tullamore builds on the strong medical device cluster in the Midlands Gateway,” concluded Mr O’Leary.